Zdrowie i gospodarka · 03/11/2022

FDA Announces Final Guidance on Cross Labeling Oncology Drugs in Combination Regimens

The US Food and Drug Administration (FDA) has released a final guidance document outlining its recommendations for including relevant information in labeling for cancer medications approved for use in combination therapies, following a draft issued in November 2020.